Rakhesh Varma

7 Global Leaders in Pharmaceutical Companies Vs 7 Indian Pharmaceutical leaders 1. Johnson & Johnson Known for its diverse portfolio of pharmaceuticals, medical devices, and consumer products. 2. Pfizer A leading biopharmaceutical company developing innovative medicines and vaccines. 3. Roche A global healthcare company focused on developing innovative medicines and diagnostics. 4. Merck & Co. A research-driven biopharmaceutical company developing innovative medicines and vaccines. 5. Novartis A global healthcare company focused on developing innovative medicines and treatments. 6. GlaxoSmithKline A global healthcare company developing innovative medicines, vaccines, and consumer healthcare products. 7. AstraZeneca A global biopharmaceutical company focused on developing innovative medicines and treatments. 7 Indian Pharmaceutical Companies 1. Sun Pharmaceutical Industries A leading pharmaceutical company in India with a strong presence in generics and specialty medicines. 2. Dr. Reddy's Laboratories A multinational pharmaceutical company developing and marketing generic medicines and APIs. 3. Cipla A leading pharmaceutical company in India with a strong presence in generics and respiratory medicines. 4. Aurobindo Pharma A leading pharmaceutical company in India with a strong presence in generics and APIs. 5. Lupin A multinational pharmaceutical company developing and marketing generic medicines and APIs. 6. Torrent Pharmaceuticals A leading pharmaceutical company in India with a strong presence in various therapeutic segments. 7. Glenmark Pharmaceuticals A research-driven pharmaceutical company developing innovative medicines and APIs. Synergistic Solutions The collaboration between global leaders and Indian pharmaceutical companies tie ups. A-Healthcare Market Reach Expanding the market reaches and increasing accessibility to medicines globally. B- Innovation in Critical Care Treatments Developing innovative treatments for critical care conditions such as cancer, cardiovascular diseases, and infectious diseases. C- Transplantation Developing innovative medicines and treatments for transplantation and organ rejection. D- Charity Collaborating on charitable initiatives to improve healthcare access and outcomes in underserved communities. E- Global Reach Leveraging global networks and expertise to develop and market medicines globally. Benefits The collaboration can benefit both global leaders and Indian pharmaceutical companies by: Enhancing Innovation Combining expertise and resources to develop innovative medicines and treatments. Increasing Market Access Expanding the market reaches and increasing accessibility to medicines globally. Improving Healthcare Outcomes Developing effective treatments and improving healthcare outcomes for patients globally. By collaborating, global leaders and Indian pharmaceutical companies can create synergistic solutions that benefit patients, healthcare providers, and the pharmaceutical industry.

302

16 Comments

Talent cannot be boxed in a grid! Grids limit possibilities and the opportunity to explore the unknowns. The 9-box grid was designed for talent. But somewhere along the way, talent started being designed for the 9-box and within the 9 box. At ETHRWorld Kochi, I challenged us to revisit the 9 box framework of talent management because talent doesn’t arrive in neat lines and boxes. It arrives like monsoon rain — sudden, uneven, life-giving. It grows like a rainforest — tangled, interwoven, quietly fierce. It moves like the ocean — shifting, deep, uncharted. It sings like a raga — with pauses, improvisations, and notes no chart can hold. Yet we keep measuring it in 9 squares. As if potential were a spreadsheet. As if growth obeyed geometry. But here’s what I’ve seen: The sapling marked “low potential” becomes the tree that shelters many. The star performer burns out when boxed too tight. And the quiet ones — the ones we overlook — often hold the rhythm of the whole team. So I ask: Why garden with grids when we could grow forests? Why chart waves when we could ride them? Why count notes when we could compose symphonies? The future of work won’t be built by classification. It will be built by cultivation. By leaders who don’t just manage talent — they believe in it. Because talent isn’t a diagram, it’s a living, breathing, unpredictable force and the bravest thing we can do is let it flow. #ETHRKochi #CHROVoices #FutureOfWork #NoMoreBoxes #RethinkTalent

1,456

116 Comments

Post 3 – Collaboration Across Borders B2B Real Time Growth | Industry Voices In my dialogue with Avinash Kumar Talwar, Vice President & Head – Strategic Procurement Packaging-Global Procurement at Dr. Reddy’s Laboratories Ltd, one point stood out clearly: collaboration is no longer local — it’s global. Avinash highlighted that packaging suppliers today operate across multiple geographies. To succeed, they must: 🔹 Align global quality standards with local execution. 🔹 Share market intelligence proactively to help customers anticipate risks. 🔹 Ensure seamless coordination across plants and regions so that customers experience one consistent face. The message was powerful: collaboration is not coordination alone; it’s anticipation, alignment, and action across borders. 👉 In B2B, growth becomes real when trust takes us beyond transactions and turns suppliers into true partners. That is why in my DIG 3x3 Coaching Framework, Trust is a critical driver in the Influence phase — because trust transforms delivery into credibility, credibility into culture, and culture into sustainable growth. Avinash Kumar Talwar Dr. Reddy's Laboratories #B2B #RealTimeGrowth #IndustryVoices #Trust #Collaboration #Influence #Leadership #CustomerPartnerships #PharmaPackaging #StrategicGrowth #mohanjoshi

58

3 Comments

🚨 “𝐈𝐧 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐬𝐚𝐥𝐞𝐬, 𝐭𝐡𝐞 𝐛𝐢𝐠𝐠𝐞𝐬𝐭 𝐡𝐞𝐚𝐥𝐭𝐡 𝐡𝐚𝐳𝐚𝐫𝐝 𝐢𝐬 𝐭𝐡𝐞 𝐣𝐨𝐛 𝐢𝐭𝐬𝐞𝐥𝐟.” After spending years in this profession, I’ve seen how much we push ourselves for patients, doctors, and organizations. But the harsh truth is — our own health often becomes the first casualty. 📊 𝐓𝐡𝐞 𝐫𝐞𝐚𝐥𝐢𝐭𝐲 𝐢𝐬 𝐚𝐥𝐚𝐫𝐦𝐢𝐧𝐠: 63% 𝐨𝐟 𝐬𝐚𝐥𝐞𝐬𝐩𝐞𝐨𝐩𝐥𝐞 𝐚𝐝𝐦𝐢𝐭 𝐭𝐡𝐞𝐲 𝐚𝐫𝐞 𝐬𝐭𝐫𝐮𝐠𝐠𝐥𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐭𝐡𝐞𝐢𝐫 𝐦𝐞𝐧𝐭𝐚𝐥 𝐡𝐞𝐚𝐥𝐭𝐡. 67% 𝐬𝐚𝐲 𝐭𝐡𝐞𝐲 𝐚𝐫𝐞 𝐜𝐥𝐨𝐬𝐞 𝐭𝐨 𝐛𝐮𝐫𝐧𝐨𝐮𝐭. In India,𝐧𝐞𝐚𝐫𝐥𝐲 1 𝐢𝐧 4 𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐩𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥𝐬 𝐬𝐡𝐨𝐰 𝐬𝐢𝐠𝐧𝐬 𝐨𝐟 𝐞𝐦𝐨𝐭𝐢𝐨𝐧𝐚𝐥 𝐞𝐱𝐡𝐚𝐮𝐬𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐛𝐮𝐫𝐧𝐨𝐮𝐭. Frequent travelers (20+ days a month) report worse physical health and higher BMI. We talk about saving patient lives every day — but what about saving our own? 💡𝐀𝐧 𝐞𝐱𝐡𝐚𝐮𝐬𝐭𝐞𝐝, 𝐛𝐮𝐫𝐧𝐞𝐝-𝐨𝐮𝐭 𝐟𝐢𝐞𝐥𝐝 𝐟𝐨𝐫𝐜𝐞 𝐜𝐚𝐧’𝐭 𝐛𝐞 𝐜𝐨𝐧𝐬𝐢𝐬𝐭𝐞𝐧𝐭, 𝐞𝐦𝐩𝐚𝐭𝐡𝐞𝐭𝐢𝐜, 𝐨𝐫 𝐞𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞. 𝐀𝐧𝐝 𝐰𝐡𝐞𝐧 𝐭𝐡𝐚𝐭 𝐡𝐚𝐩𝐩𝐞𝐧𝐬, 𝐢𝐭 𝐝𝐢𝐫𝐞𝐜𝐭𝐥𝐲 𝐢𝐦𝐩𝐚𝐜𝐭𝐬 𝐭𝐡𝐞 𝐯𝐞𝐫𝐲 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐰𝐞’𝐫𝐞 𝐡𝐞𝐫𝐞 𝐭𝐨 𝐬𝐞𝐫𝐯𝐞. 𝐓𝐡𝐚𝐭’𝐬 𝐰𝐡𝐲 𝐈 𝐛𝐞𝐥𝐢𝐞𝐯𝐞: 👉 Leaders must stop rewarding hustle alone and start investing in wellness. 👉 Teams should normalize balance over burnout. 👉 We, as individuals, need to take small but consistent steps to protect our health. 𝐁𝐞𝐜𝐚𝐮𝐬𝐞 𝐚 𝐡𝐞𝐚𝐥𝐭𝐡𝐲 𝐬𝐚𝐥𝐞𝐬 𝐟𝐨𝐫𝐜𝐞 𝐢𝐬𝐧’𝐭 𝐣𝐮𝐬𝐭 𝐠𝐨𝐨𝐝 𝐟𝐨𝐫 𝐛𝐮𝐬𝐢𝐧𝐞𝐬𝐬 — 𝐢𝐭’𝐬 𝐞𝐬𝐬𝐞𝐧𝐭𝐢𝐚𝐥 𝐟𝐨𝐫 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐚𝐭 𝐥𝐚𝐫𝐠𝐞. 💬𝐈 𝐰𝐚𝐧𝐭 𝐭𝐨 𝐡𝐞𝐚𝐫 𝐟𝐫𝐨𝐦 𝐦𝐲 𝐧𝐞𝐭𝐰𝐨𝐫𝐤: 𝐖𝐡𝐚𝐭’𝐬 𝐨𝐧𝐞 𝐡𝐚𝐛𝐢𝐭 𝐲𝐨𝐮’𝐯𝐞 𝐛𝐮𝐢𝐥𝐭 (𝐨𝐫 𝐰𝐢𝐬𝐡 𝐲𝐨𝐮 𝐡𝐚𝐝) 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐡𝐞𝐚𝐥𝐭𝐡𝐲 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐝𝐞𝐦𝐚𝐧𝐝𝐢𝐧𝐠 𝐩𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧? #HealthcareSales #SalesLeadership #FieldForce #BurnoutAwareness #EmployeeWellbeing #SalesForceEffectiveness #HealthcareProfessionals #WorkplaceWellness #SalesCulture #MentalHealthAtWork #HealthcareIndustry #HealthyWorkforce #SalesCommunity #FieldForceExcellence #LeadershipMatters

47

5 Comments

The USFDA isn’t a hurdle. It’s a growth strategy 📈 Every company dreads inspections. But here’s the truth: ▪️ The most resilient Indian pharma companies embrace the USFDA — and build to meet it. ▪️ A successful USFDA audit isn’t just a compliance win. It’s a passport to global trust, investor confidence, and long-term margins. Instead of fearing the regulator, let’s build for the world 🌍 That’s how Indian pharma scales.

79

9 Comments